Chargement en cours...
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
Colorectal cancer (CRC) is a leading cause of tumor-related morbidity and mortality worldwide, with mortality most often attributable to metastatic disease. Bevacizumab, a humanized monoclonal antibody targeting vascular endothelial growth factor, has a significant role in the treatment of metastati...
Enregistré dans:
| Publié dans: | Target Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5610666/ https://ncbi.nlm.nih.gov/pubmed/28801849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-017-0518-1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|